Search research articles
Contact Us
Filters
Showing results (111-120 of 211) with videos related to
Page
of 22
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 1, 1989
Castration induced by cytotoxic chemotherapy
H Brincker, H T Mouridsen, K W Andersen, et al.
Cancer Treatment Reports
|
October 1, 1984
Phase II study of teniposide in small cell carcinoma of the lung
A G Pedersen, E Bork, K Osterlind, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1989
Prospective evaluation of chronic cardiotoxicity due to high-dose epirubicin or combination chemotherapy with cyclophosphamide, methotrexate, and 5-fluorouracil
H Havsteen, I Brynjolf, T Svahn, et al.
Gynecologic Oncology
|
July 1, 1999
Assessment of biological variation and analytical imprecision of CA 125, CEA, and TPA in relation to monitoring of ovarian cancer
M K Tuxen, G Sölétormos, P H Petersen, et al.
Cancer Chemotherapy and Pharmacology
|
January 4, 2001
Epirubicin or epirubicin and cisplatin as first-line therapy in advanced breast cancer. A phase III study
D Nielsen, P Dombernowsky, S K Larsen, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1993
Phase II study of 4'-iodo-4'-deoxydoxorubicin in non-resectable non-small-cell lung cancer
J B Sørensen, L Stenbygaard, L Drivsholm, et al.
Cancer Treatment Reports
|
February 1, 1982
Phase II study of procarbazine in small cell carcinoma of the lung
A G Pedersen, S Sörenson, K Aabo, et al.
Ugeskrift for Laeger
|
January 29, 1973
[Use of chemotherapy in combination with surgery and irradiation in cases of nephroblastoma (Wilm's tumor)]
P Dombernowsky, K Dano, K Mauritzen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 1, 1986
Long-term disease-free survival in small-cell carcinoma of the lung: a study of clinical determinants
K Osterlind, H H Hansen, M Hansen, et al.
Seminars in Oncology
|
February 1, 1996
Paclitaxel and doxorubicin, a highly active combination in the treatment of metastatic breast cancer
P Dombernowsky, J Gehl, M Boesgaard, et al.
Page
of 22
Search research articles
Search
Showing results (111-120 of 211) with videos related to
Sort By:
Page
of 22
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 1, 1989
Castration induced by cytotoxic chemotherapy
H Brincker, H T Mouridsen, K W Andersen, et al.
Cancer Treatment Reports
|
October 1, 1984
Phase II study of teniposide in small cell carcinoma of the lung
A G Pedersen, E Bork, K Osterlind, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1989
Prospective evaluation of chronic cardiotoxicity due to high-dose epirubicin or combination chemotherapy with cyclophosphamide, methotrexate, and 5-fluorouracil
H Havsteen, I Brynjolf, T Svahn, et al.
Gynecologic Oncology
|
July 1, 1999
Assessment of biological variation and analytical imprecision of CA 125, CEA, and TPA in relation to monitoring of ovarian cancer
M K Tuxen, G Sölétormos, P H Petersen, et al.
Cancer Chemotherapy and Pharmacology
|
January 4, 2001
Epirubicin or epirubicin and cisplatin as first-line therapy in advanced breast cancer. A phase III study
D Nielsen, P Dombernowsky, S K Larsen, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1993
Phase II study of 4'-iodo-4'-deoxydoxorubicin in non-resectable non-small-cell lung cancer
J B Sørensen, L Stenbygaard, L Drivsholm, et al.
Cancer Treatment Reports
|
February 1, 1982
Phase II study of procarbazine in small cell carcinoma of the lung
A G Pedersen, S Sörenson, K Aabo, et al.
Ugeskrift for Laeger
|
January 29, 1973
[Use of chemotherapy in combination with surgery and irradiation in cases of nephroblastoma (Wilm's tumor)]
P Dombernowsky, K Dano, K Mauritzen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 1, 1986
Long-term disease-free survival in small-cell carcinoma of the lung: a study of clinical determinants
K Osterlind, H H Hansen, M Hansen, et al.
Seminars in Oncology
|
February 1, 1996
Paclitaxel and doxorubicin, a highly active combination in the treatment of metastatic breast cancer
P Dombernowsky, J Gehl, M Boesgaard, et al.
Page
of 22